Cargando…
Antitumor activity of mixed heat shock protein/peptide vaccine and cyclophosphamide plus interleukin-12 in mice sarcoma
BACKGROUND: The immune factors heat shock protein (HSP)/peptides (HSP/Ps) can induce both adaptive and innate immune responses. Treatment with HSP/Ps in cancer cell-bearing mice and cancer patients revealed antitumor immune activity. We aimed to develop immunotherapy strategies by vaccination with a...
Autores principales: | Guo, Quan-Yi, Yuan, Mei, Peng, Jiang, Cui, Xue-Mei, Song, Ge, Sui, Xiang, Lu, Shi-Bi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056821/ https://www.ncbi.nlm.nih.gov/pubmed/21352555 http://dx.doi.org/10.1186/1756-9966-30-24 |
Ejemplares similares
-
Prophylactic Antitumor Effect of Mixed Heat Shock Proteins/Peptides in Mouse Sarcoma
por: Wang, Yu, et al.
Publicado: (2015) -
Antitumor Activities of Interleukin-12 in Melanoma
por: Gao, Wei, et al.
Publicado: (2022) -
Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma
por: Blanchette, P., et al.
Publicado: (2012) -
Beneficial effects of 20(S)-protopanaxadiol on antitumor activity and toxicity of cyclophosphamide in tumor-bearing mice
por: LIN, GUANGZHU, et al.
Publicado: (2013) -
X66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock response
por: Zhao, Zhixin, et al.
Publicado: (2016)